vs
PHINIA INC.（PHIN）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
PHINIA INC.的季度营收约是Revvity的1.2倍（$889.0M vs $772.1M），PHINIA INC.同比增速更快（6.7% vs 5.9%），Revvity自由现金流更多（$161.8M vs $67.0M），过去两年Revvity的营收复合增速更高（9.0% vs 1.5%）
PHINIA INC.是一家全球汽车技术供应商，主打燃油喷射系统、起动机、发电机及混动、电动汽车零部件，服务全球各主要市场的整车生产商和售后客户，覆盖乘用车、商用车及工业出行领域。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
PHIN vs RVTY — 直观对比
营收规模更大
PHIN
是对方的1.2倍
$772.1M
营收增速更快
PHIN
高出0.9%
5.9%
自由现金流更多
RVTY
多$94.8M
$67.0M
两年增速更快
RVTY
近两年复合增速
1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $889.0M | $772.1M |
| 净利润 | — | $98.4M |
| 毛利率 | 21.7% | — |
| 营业利润率 | 7.8% | 14.5% |
| 净利率 | — | 12.7% |
| 营收同比 | 6.7% | 5.9% |
| 净利润同比 | — | 3.9% |
| 每股收益（稀释后） | $1.14 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PHINRVTY
| Q4 25 | $889.0M | $772.1M | ||
| Q3 25 | $908.0M | $698.9M | ||
| Q2 25 | $890.0M | $720.3M | ||
| Q1 25 | $796.0M | $664.8M | ||
| Q4 24 | $833.0M | $729.4M | ||
| Q3 24 | $839.0M | $684.0M | ||
| Q2 24 | $868.0M | $691.7M | ||
| Q1 24 | $863.0M | $649.9M |
净利润PHINRVTY
| Q4 25 | — | $98.4M | ||
| Q3 25 | $13.0M | $46.7M | ||
| Q2 25 | $46.0M | $53.9M | ||
| Q1 25 | $26.0M | $42.2M | ||
| Q4 24 | — | $94.6M | ||
| Q3 24 | $31.0M | $94.4M | ||
| Q2 24 | $14.0M | $55.4M | ||
| Q1 24 | $29.0M | $26.0M |
毛利率PHINRVTY
| Q4 25 | 21.7% | — | ||
| Q3 25 | 22.0% | 53.6% | ||
| Q2 25 | 22.1% | 54.5% | ||
| Q1 25 | 21.6% | 56.5% | ||
| Q4 24 | 22.7% | — | ||
| Q3 24 | 22.3% | 56.3% | ||
| Q2 24 | 21.7% | 55.7% | ||
| Q1 24 | 22.2% | 54.6% |
营业利润率PHINRVTY
| Q4 25 | 7.8% | 14.5% | ||
| Q3 25 | 3.7% | 11.7% | ||
| Q2 25 | 10.0% | 12.6% | ||
| Q1 25 | 7.8% | 10.9% | ||
| Q4 24 | 6.1% | 16.3% | ||
| Q3 24 | 7.9% | 14.3% | ||
| Q2 24 | 8.2% | 12.4% | ||
| Q1 24 | 8.2% | 6.8% |
净利率PHINRVTY
| Q4 25 | — | 12.7% | ||
| Q3 25 | 1.4% | 6.7% | ||
| Q2 25 | 5.2% | 7.5% | ||
| Q1 25 | 3.3% | 6.4% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | 3.7% | 13.8% | ||
| Q2 24 | 1.6% | 8.0% | ||
| Q1 24 | 3.4% | 4.0% |
每股收益（稀释后）PHINRVTY
| Q4 25 | $1.14 | $0.86 | ||
| Q3 25 | $0.33 | $0.40 | ||
| Q2 25 | $1.14 | $0.46 | ||
| Q1 25 | $0.63 | $0.35 | ||
| Q4 24 | $0.13 | $0.77 | ||
| Q3 24 | $0.70 | $0.77 | ||
| Q2 24 | $0.31 | $0.45 | ||
| Q1 24 | $0.62 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $359.0M | $919.9M |
| 总债务越低越好 | $970.0M | — |
| 股东权益账面价值 | $1.6B | $7.3B |
| 总资产 | $3.8B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.61× | — |
8季度趋势，按日历期对齐
现金及短期投资PHINRVTY
| Q4 25 | $359.0M | $919.9M | ||
| Q3 25 | $349.0M | $931.4M | ||
| Q2 25 | $347.0M | $991.8M | ||
| Q1 25 | $373.0M | $1.1B | ||
| Q4 24 | $484.0M | $1.2B | ||
| Q3 24 | $477.0M | $1.2B | ||
| Q2 24 | $339.0M | $2.0B | ||
| Q1 24 | $325.0M | $1.7B |
总债务PHINRVTY
| Q4 25 | $970.0M | — | ||
| Q3 25 | $990.0M | — | ||
| Q2 25 | $990.0M | — | ||
| Q1 25 | $989.0M | — | ||
| Q4 24 | $988.0M | — | ||
| Q3 24 | $987.0M | — | ||
| Q2 24 | $821.0M | — | ||
| Q1 24 | $706.0M | — |
股东权益PHINRVTY
| Q4 25 | $1.6B | $7.3B | ||
| Q3 25 | $1.6B | $7.4B | ||
| Q2 25 | $1.6B | $7.6B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.6B | $7.7B | ||
| Q3 24 | $1.7B | $7.9B | ||
| Q2 24 | $1.7B | $7.9B | ||
| Q1 24 | $1.9B | $7.8B |
总资产PHINRVTY
| Q4 25 | $3.8B | $12.2B | ||
| Q3 25 | $4.0B | $12.1B | ||
| Q2 25 | $3.9B | $12.4B | ||
| Q1 25 | $3.7B | $12.4B | ||
| Q4 24 | $3.8B | $12.4B | ||
| Q3 24 | $4.0B | $12.8B | ||
| Q2 24 | $3.9B | $13.4B | ||
| Q1 24 | $4.0B | $13.4B |
负债/权益比PHINRVTY
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.64× | — | ||
| Q4 24 | 0.63× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.38× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $96.0M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $67.0M | $161.8M |
| 自由现金流率自由现金流/营收 | 7.5% | 21.0% |
| 资本支出强度资本支出/营收 | 3.3% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | $188.0M | $509.4M |
8季度趋势，按日历期对齐
经营现金流PHINRVTY
| Q4 25 | $96.0M | $182.0M | ||
| Q3 25 | $119.0M | $138.5M | ||
| Q2 25 | $57.0M | $134.3M | ||
| Q1 25 | $40.0M | $128.2M | ||
| Q4 24 | $73.0M | $174.2M | ||
| Q3 24 | $95.0M | $147.9M | ||
| Q2 24 | $109.0M | $158.6M | ||
| Q1 24 | $31.0M | $147.6M |
自由现金流PHINRVTY
| Q4 25 | $67.0M | $161.8M | ||
| Q3 25 | $93.0M | $120.0M | ||
| Q2 25 | $23.0M | $115.5M | ||
| Q1 25 | $5.0M | $112.2M | ||
| Q4 24 | $53.0M | $149.8M | ||
| Q3 24 | $70.0M | $125.6M | ||
| Q2 24 | $92.0M | $136.6M | ||
| Q1 24 | $-12.0M | $129.7M |
自由现金流率PHINRVTY
| Q4 25 | 7.5% | 21.0% | ||
| Q3 25 | 10.2% | 17.2% | ||
| Q2 25 | 2.6% | 16.0% | ||
| Q1 25 | 0.6% | 16.9% | ||
| Q4 24 | 6.4% | 20.5% | ||
| Q3 24 | 8.3% | 18.4% | ||
| Q2 24 | 10.6% | 19.7% | ||
| Q1 24 | -1.4% | 20.0% |
资本支出强度PHINRVTY
| Q4 25 | 3.3% | 2.6% | ||
| Q3 25 | 2.9% | 2.6% | ||
| Q2 25 | 3.8% | 2.6% | ||
| Q1 25 | 4.4% | 2.4% | ||
| Q4 24 | 2.4% | 3.4% | ||
| Q3 24 | 3.0% | 3.3% | ||
| Q2 24 | 2.0% | 3.2% | ||
| Q1 24 | 5.0% | 2.7% |
现金转化率PHINRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | 9.15× | 2.97× | ||
| Q2 25 | 1.24× | 2.49× | ||
| Q1 25 | 1.54× | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | 3.06× | 1.57× | ||
| Q2 24 | 7.79× | 2.87× | ||
| Q1 24 | 1.07× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PHIN
| Customer | $618.0M | 70% |
| Fuel Systems | $194.0M | 22% |
| Other | $77.0M | 9% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
